> The U.K. government-backed Biomedical Catalyst program has awarded £1.4 million ($2.2 million) to the Q-CANCER project, which includes QuantuMDx Group's rapid on‐chip lab, leading to the first sub-20-minute tumor profiler. Press release
> The EU has awarded an international consortium, which includes University College Cork, Pronota and Metabolomic Diagnostics, €6 million ($7.7 million) to bring a predictive preeclampsia test to market. Press release
> Saskatoon, Canada-based Phenomenome Discoveries has launched its colorectal cancer screening test, Cologic. Article
> A cathepsin-based blood test could predict drug responses in atherosclerosis, osteoporosis or cancer. Press release
> Empire Genomics is developing a blood DNA marker test for multiple myeloma, which will help doctors to tailor treatment. Article
And Finally… Transdermal device could monitor biomarkers in real time. Article